Accidental Hepatitis-B-Surface-Antigen-Positive Inoculations

Use of e Antigen to Estimate Infectivity

  1. BARBARA G. WERNER, Ph.D.; and
  2. GEORGE F. GRADY, M.D.
  1. Boston, Massachusetts

    Abstract

    We assessed the ability of radioimmunoassay for hepatitis B e antigen (HBeAg) to predict infectivity in exposed medical personnel by analyzing 390 samples of sera positive for hepatitis B surface antigen (HBsAg) that were implicated in accidental inoculations of known outcome. The radioimmunoassay detected HBeAg or its antibody (anti-HBe) in 91% of the donor sera. The incidence of hepatitis B was 19% (44 of 234) in recipients of HBeAg-positive sera but was only 2.5% (three of 121) in recipients of sera positive for anti-HBe, and nil (none of 35) in recipients of sera negative for HBeAg and anti-HBe. The known relation of HBeAg and infectivity was quantified by radioimmunoassay as a risk ratio of 10:1 (HBeAg-positive to HBeAg-negative) for this type of exposure. The sensitivity of the radioimmunoassay also showed that a large proportion (55%) of donor sera not producing hepatitis were positive for HBeAg; therefore, even the most flagrant needlestick exposures to HBsAg-positive sera often must involve subthreshold amounts of infective material.

    Article and Author Information

    • ▸From the State Laboratory Institute, Massachusetts Department of Public Health and the Department of Medicine, Tufts University School of Medicine; Boston, Massachusetts.

    • ▸Requests for reprints should be addressed to Barbara G. Werner, Ph.D.; State Laboratory Institute, 305 South Street; Jamaica Plain, MA 02130.

    | Table of Contents
    Most Read Most Read
    Most Commented Most Commented On
    Annals in the News Annals in the News
    Clinical Trials Clinical Trials
    Comparative Effectiveness Comparative Effectiveness
    Hospital Medicine Hospital Medicine
    • Advertisement
    • Advertisement